- $1.14bn
- $1.08bn
- $83.81m
IRadimed Corp expected to post earnings of 28 cents a share - Earnings Preview
IRadimed Corp reports results for the quarter ended in December - Earnings Summary
Brief: IRADIMED Announces Fourth Quarter And Full Year 2022 Financial Results
Brief: IRadimed Expects Q1 Adjusted EPS between $0.26-$0.28
IRadimed Corp expected to post earnings of 30cents a share - Earnings Preview
IRadimed gains on higher prelim Q4 revenue
Brief: IRADIMED CORPORATION Announces Preliminary Financial Results For Q4 2022
Brief: IRadimed Forecasts Q1 EPS in range of $0.23 to $0.25
IRadimed Corp reports results for the quarter ended in September - Earnings Summary
Brief: IRadimed Corp Announces Third Quarter 2022 Financial Results
IRadimed Corp expected to post earnings of 25cents a share - Earnings Preview
IRadimed Corp expected to post earnings of 25cents a share - Earnings Preview
Brief: IRadimed Corporation Withdraws 510(K) With Plans To Resubmit After Further Discussions With FDA
Brief: IRadimed Announces Appointment Of Hilda Scharen-Guivel To Board
Brief: IRadimed Says Board Increased Size To Five Directors
IRadimed Corp reports results for the quarter ended in June - Earnings Summary
IRadimed Corp expected to post earnings of 24 cents a share - Earnings Preview
IRadimed Corp reports results for the quarter ended in March - Earnings Summary
Brief: Iradimed Corp Announces First Quarter 2022 Financial Results